Literature DB >> 21944738

Comparison of A1C, fasting and 2-h post-load plasma glucose criteria to diagnose diabetes in Italian Caucasians.

M A Marini1, E Succurro, F Arturi, M F Ruffo, F Andreozzi, A Sciacqua, R Lauro, M L Hribal, F Perticone, G Sesti.   

Abstract

BACKGROUND AND AIMS: The American Diabetes Association (ADA) has revised criteria for diagnosis of type 2 diabetes recommending an A1C cut point of ≥6.5% in addition to criteria based on glucose levels. We compared A1C, fasting plasma glucose (FPG) or 2-h post-challenge glucose (2-hPG) criteria for the diagnosis of diabetes in a cohort of Italian Caucasians. METHODS AND
RESULTS: A total of 1019 individuals without known diabetes completed an oral glucose tolerance test (OGTT) and had A1C measured. Moderate agreement existed for A1C and FPG criteria for diagnosis of type 2 diabetes (κ coefficient = 0.522), with 85.5% of individuals classified as not having diabetes by both A1C and FPG criteria, and 5.8% classified as having diabetes by both A1C and FPG criteria. Discordant classifications occurred for 5.5% of individuals who had an A1C ≥ 6.5% and FPG <126 mg dl(-1), and for 3.2% who had an A1C <6.5% and FPG ≥126 mg dl(-1). Modest agreement existed for A1C and 2-hPG criteria for diagnosis of type 2 diabetes (κ coefficient = 0.427), with 81.8% of individuals classified as not having diabetes by both A1C and 2-hPG criteria, and 6.0% classified as having diabetes by both A1C and 2-hPG criteria. The area under the receiver operating characteristic curve of A1C for identifying subjects with diabetes according to FPG or 2-hPG criteria was 0.856 and 0.794, respectively. Modest agreement existed for A1C and FPG and/or 2-hPG criteria for diagnosis of type 2 diabetes (κ coefficient = 0.446).
CONCLUSIONS: A1C ≥ 6.5% demonstrates a moderate agreement with fasting glucose and 2-hPG for diagnosing diabetes among adult Italian Caucasians subjects.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21944738     DOI: 10.1016/j.numecd.2011.04.009

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  7 in total

1.  Comparing glucose and hemoglobin A1c diagnostic tests among a high metabolic risk Hispanic population.

Authors:  Mónica A Vega-Vázquez; Margarita Ramírez-Vick; Francisco J Muñoz-Torres; Loida A González-Rodríguez; Kaumudi Joshipura
Journal:  Diabetes Metab Res Rev       Date:  2017-02-02       Impact factor: 4.876

2.  Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria.

Authors:  Maria A Marini; Elena Succurro; Ersilia Castaldo; Sabrina Cufone; Franco Arturi; Angela Sciacqua; Renato Lauro; Marta L Hribal; Francesco Perticone; Giorgio Sesti
Journal:  Diabetes Care       Date:  2012-03-07       Impact factor: 19.112

3.  Glycated Hemoglobin Measurement: Comparison of Three Methods Versus High Performance Liquid Chromatography.

Authors:  María Zulema Chaila; Matías Viniegra; Juan José Gagliardino; Alfredo Martínez; María Gabriela Simesen de Bielke; Mauro Frusti; Luis Monaco; Pablo Salgado; Carlos Buso; Claudio Daniel Gonzalez; Víctor Francisco Commendatore
Journal:  J Diabetes Sci Technol       Date:  2021-03-09

4.  Comparison of the Current Diagnostic Criterion of HbA1c with Fasting and 2-Hour Plasma Glucose Concentration.

Authors:  Rudruidee Karnchanasorn; Jean Huang; Horng-Yih Ou; Wei Feng; Lee-Ming Chuang; Ken C Chiu; Raynald Samoa
Journal:  J Diabetes Res       Date:  2016-08-11       Impact factor: 4.011

5.  Dysglycemia and increased left ventricle mass in normotensive patients admitted with a first myocardial infarction: prognostic implications of dysglycemia during 14 years of follow-up.

Authors:  Gokulan Pararajasingam; Brian Bridal Løgstrup; Dan Eik Høfsten; Thomas Brøcher Christophersen; Søren Auscher; Jørgen Hangaard; Kenneth Egstrup
Journal:  BMC Cardiovasc Disord       Date:  2019-05-02       Impact factor: 2.298

6.  Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance.

Authors:  Cristina Bianchi; Roberto Miccoli; Riccardo C Bonadonna; Francesco Giorgino; Simona Frontoni; Emanuela Faloia; Giulio Marchesini; Maria A Dolci; Franco Cavalot; Gisella M Cavallo; Frida Leonetti; Stefano Del Prato
Journal:  Diabetes Care       Date:  2012-08-21       Impact factor: 19.112

7.  Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction.

Authors:  Teresa Vanessa Fiorentino; Maria Adelaide Marini; Elena Succurro; Angela Sciacqua; Francesco Andreozzi; Francesco Perticone; Giorgio Sesti
Journal:  Oncotarget       Date:  2017-06-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.